Please enable JavaScript to continue using this application.

Compare $CNTB vs $GOSS | Chartloom

Compare

$CNTB vs $GOSS

Connect Biopharma Holdings Ltd · Gossamer Bio Inc

CNTB

Connect Biopharma Holdings Ltd

GOSS

Gossamer Bio Inc

Compare $CNTB vs $GOSS

Comparing Connect Biopharma Holdings Ltd and Gossamer Bio Inc

CNTBConnect Biopharma Holdings Ltd

GOSSGossamer Bio Inc

CNTBConnect Biopharma Holdings Ltd

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.55x

Rev growth (TTM)

—

YTD performance

-65.5%

52W performance

-52.2%

FCF yield

-125.1%

GOSSGossamer Bio Inc

Market cap

$4.55B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

32.4%

YTD performance

-96.0%

52W performance

-95.2%

FCF yield

-3.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNTB

GOSS

Detailed metrics comparison

CNTB

Connect Biopharma Holdings Ltd

GOSS

Gossamer Bio Inc

Market Cap

CNTB$48M

GOSS$4.55B

Enterprise Value

CNTB$21M

GOSS$4.55B

Price

CNTB$0.87

GOSS$9.31

P/E Ratio

CNTBN/A

GOSSN/A

P/S Ratio

CNTB16.42x

GOSS85.41x

EV/Sales

CNTB7.27x

GOSS85.32x

EV/EBITDA

CNTB0.00x

GOSS0.00x

P/B Ratio

CNTB2.17x

GOSS2.26x

P/FCF Ratio

CNTBN/A

GOSSN/A

EV/FCF

CNTB-0.35x

GOSS-27.95x

PEG Ratio

CNTBN/A

GOSSN/A

Forward P/E (NTM)

CNTBN/A

GOSSN/A

Forward P/S (NTM)

CNTB5.55x

GOSSN/A

Revenue (TTM)

CNTB$3M

GOSS$53M

Revenue Growth (YoY)

CNTBN/A

GOSS32.4%

Forward Rev Growth

CNTB98.8%

GOSS50.5%

Gross Margin (TTM)

CNTB0.0%

GOSS0.0%

Operating Margin (TTM)

CNTB0.0%

GOSS0.0%

EBITDA Margin (TTM)

CNTB-2361.3%

GOSS-297.6%

Net Margin (TTM)

CNTB-2336.3%

GOSS-235.0%

FCF Margin (TTM)

CNTB-2053.3%

GOSS-305.2%

Net Income (TTM)

CNTB$-69M

GOSS$-125M

FCF (TTM)

CNTB$-61M

GOSS$-163M

EPS (TTM)

CNTB-$1.24

GOSS-$0.38

ROE (TTM)

CNTB-16541.0%

GOSS-11877.0%

ROA (TTM)

CNTB-12158.0%

GOSS-8535.0%

ROIC (TTM)

CNTB-16541.0%

GOSS-2300.0%

Cash

CNTB$27M

GOSS$41M

Debt

CNTB$0

GOSS$36M

Net Cash/Debt

CNTB$27M

GOSS$5M

Current Ratio (TTM)

CNTB2.37x

GOSS0.53x

Quick Ratio (TTM)

CNTB2.11x

GOSS0.46x

Debt/Equity (TTM)

CNTB0.00x

GOSS6.83x

Debt/Assets (TTM)

CNTB0.0%

GOSS0.0%

Interest Coverage (TTM)

CNTBN/A

GOSSN/A

Net Debt/EBITDA (TTM)

CNTB0.00x

GOSS0.00x

Beta

CNTB-0.07

GOSS2.28

52W Performance

CNTB-52.2%

GOSS-95.2%

YTD Performance

CNTB-65.5%

GOSS-96.0%

% from 52W High

CNTB-77.2%

GOSS-97.0%

% from 52W Low

CNTB2.3%

GOSS2.3%

Asset Turnover (TTM)

CNTB0.05x

GOSS0.36x

FCF Yield (TTM)

CNTB-125.1%

GOSS-3.6%

Earnings Yield (TTM)

CNTB-142.3%

GOSS-2.8%

Dividend Yield (TTM)

CNTBN/A

GOSSN/A

Rule of 40

CNTB-2,053.3

GOSS-272.8

EV/GP/RG

CNTBN/A

GOSSN/A

Ticker research

View CNTB research View GOSS research

Metric	CNTB Connect Biopharma Holdings Ltd	GOSS Gossamer Bio Inc
Market & Valuation
Market Cap	$48M	$4.55B
Enterprise Value	$21M	$4.55B
Price	$0.87	$9.31
P/E Ratio	N/A	N/A
P/S Ratio	16.42x	85.41x
EV/Sales	7.27x	85.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.17x	2.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.35x	-27.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.55x	N/A
Revenue & Growth
Revenue (TTM)	$3M	$53M
Revenue Growth (YoY)	N/A	32.4%
Forward Rev Growth	98.8%	50.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2361.3%	-297.6%
Net Margin (TTM)	-2336.3%	-235.0%
FCF Margin (TTM)	-2053.3%	-305.2%
Net Income (TTM)	$-69M	$-125M
FCF (TTM)	$-61M	$-163M
EPS (TTM)	-$1.24	-$0.38
ROE (TTM)	-16541.0%	-11877.0%
ROA (TTM)	-12158.0%	-8535.0%
ROIC (TTM)	-16541.0%	-2300.0%
Financial Health
Cash	$27M	$41M
Debt	$0	$36M
Net Cash/Debt	$27M	$5M
Current Ratio (TTM)	2.37x	0.53x
Quick Ratio (TTM)	2.11x	0.46x
Debt/Equity (TTM)	0.00x	6.83x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	2.28
52W Performance	-52.2%	-95.2%
YTD Performance	-65.5%	-96.0%
% from 52W High	-77.2%	-97.0%
% from 52W Low	2.3%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.36x
FCF Yield (TTM)	-125.1%	-3.6%
Earnings Yield (TTM)	-142.3%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,053.3	-272.8
EV/GP/RG	N/A	N/A
Ticker research	View CNTB research	View GOSS research

Valuation

P/S Ratio

CNTB

16.42x

GOSS

85.41x

EV/FCF

GOSS

-27.95x

CNTB

-0.35x

Growth & revenue

Revenue Growth TTM

GOSS

32.4%

Forward Revenue Growth

CNTB

98.8%

GOSS

50.5%

Profitability & performance

Gross Margin

CNTB

0.0%

GOSS

0.0%

ROE

GOSS

-11877.0%

CNTB

-16541.0%

FCF Yield %

GOSS

-3.6%

CNTB

-125.1%

52-Week Performance

CNTB

-52.2%

GOSS

-95.2%

Detailed metrics comparison

CNTB

Connect Biopharma Holdings Ltd

GOSS

Gossamer Bio Inc

Market Cap

CNTB$48M

GOSS$4.55B

Enterprise Value

CNTB$21M

GOSS$4.55B

Price

CNTB$0.87

GOSS$9.31

P/E Ratio

CNTBN/A

GOSSN/A

P/S Ratio

CNTB16.42x

GOSS85.41x

EV/Sales

CNTB7.27x

GOSS85.32x

EV/EBITDA

CNTB0.00x

GOSS0.00x

P/B Ratio

CNTB2.17x

GOSS2.26x

P/FCF Ratio

CNTBN/A

GOSSN/A

EV/FCF

CNTB-0.35x

GOSS-27.95x

PEG Ratio

CNTBN/A

GOSSN/A

Forward P/E (NTM)

CNTBN/A

GOSSN/A

Forward P/S (NTM)

CNTB5.55x

GOSSN/A

Revenue (TTM)

CNTB$3M

GOSS$53M

Revenue Growth (YoY)

CNTBN/A

GOSS32.4%

Forward Rev Growth

CNTB98.8%

GOSS50.5%

Gross Margin (TTM)

CNTB0.0%

GOSS0.0%

Operating Margin (TTM)

CNTB0.0%

GOSS0.0%

EBITDA Margin (TTM)

CNTB-2361.3%

GOSS-297.6%

Net Margin (TTM)

CNTB-2336.3%

GOSS-235.0%

FCF Margin (TTM)

CNTB-2053.3%

GOSS-305.2%

Net Income (TTM)

CNTB$-69M

GOSS$-125M

FCF (TTM)

CNTB$-61M

GOSS$-163M

EPS (TTM)

CNTB-$1.24

GOSS-$0.38

ROE (TTM)

CNTB-16541.0%

GOSS-11877.0%

ROA (TTM)

CNTB-12158.0%

GOSS-8535.0%

ROIC (TTM)

CNTB-16541.0%

GOSS-2300.0%

Cash

CNTB$27M

GOSS$41M

Debt

CNTB$0

GOSS$36M

Net Cash/Debt

CNTB$27M

GOSS$5M

Current Ratio (TTM)

CNTB2.37x

GOSS0.53x

Quick Ratio (TTM)

CNTB2.11x

GOSS0.46x

Debt/Equity (TTM)

CNTB0.00x

GOSS6.83x

Debt/Assets (TTM)

CNTB0.0%

GOSS0.0%

Interest Coverage (TTM)

CNTBN/A

GOSSN/A

Net Debt/EBITDA (TTM)

CNTB0.00x

GOSS0.00x

Beta

CNTB-0.07

GOSS2.28

52W Performance

CNTB-52.2%

GOSS-95.2%

YTD Performance

CNTB-65.5%

GOSS-96.0%

% from 52W High

CNTB-77.2%

GOSS-97.0%

% from 52W Low

CNTB2.3%

GOSS2.3%

Asset Turnover (TTM)

CNTB0.05x

GOSS0.36x

FCF Yield (TTM)

CNTB-125.1%

GOSS-3.6%

Earnings Yield (TTM)

CNTB-142.3%

GOSS-2.8%

Dividend Yield (TTM)

CNTBN/A

GOSSN/A

Rule of 40

CNTB-2,053.3

GOSS-272.8

EV/GP/RG

CNTBN/A

GOSSN/A

Ticker research

View CNTB research View GOSS research

Metric	CNTB Connect Biopharma Holdings Ltd	GOSS Gossamer Bio Inc
Market & Valuation
Market Cap	$48M	$4.55B
Enterprise Value	$21M	$4.55B
Price	$0.87	$9.31
P/E Ratio	N/A	N/A
P/S Ratio	16.42x	85.41x
EV/Sales	7.27x	85.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.17x	2.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.35x	-27.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.55x	N/A
Revenue & Growth
Revenue (TTM)	$3M	$53M
Revenue Growth (YoY)	N/A	32.4%
Forward Rev Growth	98.8%	50.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2361.3%	-297.6%
Net Margin (TTM)	-2336.3%	-235.0%
FCF Margin (TTM)	-2053.3%	-305.2%
Net Income (TTM)	$-69M	$-125M
FCF (TTM)	$-61M	$-163M
EPS (TTM)	-$1.24	-$0.38
ROE (TTM)	-16541.0%	-11877.0%
ROA (TTM)	-12158.0%	-8535.0%
ROIC (TTM)	-16541.0%	-2300.0%
Financial Health
Cash	$27M	$41M
Debt	$0	$36M
Net Cash/Debt	$27M	$5M
Current Ratio (TTM)	2.37x	0.53x
Quick Ratio (TTM)	2.11x	0.46x
Debt/Equity (TTM)	0.00x	6.83x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	2.28
52W Performance	-52.2%	-95.2%
YTD Performance	-65.5%	-96.0%
% from 52W High	-77.2%	-97.0%
% from 52W Low	2.3%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.36x
FCF Yield (TTM)	-125.1%	-3.6%
Earnings Yield (TTM)	-142.3%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,053.3	-272.8
EV/GP/RG	N/A	N/A
Ticker research	View CNTB research	View GOSS research